Brenda Christian is Director of Product and Project Management. Ms. Christian has over 15 years of experience in the Biotech industry, from research & development to late phase (Phase III) clinical trials, with a Project Management Profession (PMP®) accreditation since 2005. As Director of Project Management at Oncothyreon (formerly Biomira Inc), Ms. Christian has worked with established biotech companies and managed project teams comprised of midsize biotech and large pharmaceutical team members across several geographic locations. As Project Leader for the cancer vaccine L-BLP25, she was responsible for development of the vaccine up to the point of Merck acquiring the vaccine at Phase III stage of clinical development. She has the expertise to lead project teams with team members in several cross-functional portfolios, coordinating key activities required to develop and maintain project plans and schedules in all phases of clinical development of biotech products. Additionally, Ms. Christian has the experience to guide the execution of project plans to align with corporate strategy. She has significant experience in identifying risk factors in the development of products, working with the project team to develop mitigation strategies to address these risks, proactively define problems, develop sound creative solutions with a project team, and implement solutions with a project team to meet aggressive timelines. She has developed Project Management Offices in organizations for the purpose of standardizing methodology for managing all corporate projects.